Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629446 · ClinicalTrials.gov registry record · Phase 1

Lofexidine Mass Balance in Volunteers

A Phase 1 study of Normal Healthy Volunteers, sponsored by USWM, LLC (dba US WorldMeds).

Completed
Registry status
Phase 1
Development phase
6
Enrollment target
1
Study location

NCT01629446 is a Phase 1 study of Normal Healthy Volunteers that has completed, run by USWM, LLC (dba US WorldMeds). The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629446, a Phase 1 study of Normal Healthy Volunteers, has completed, sponsored by USWM, LLC (dba US WorldMeds).

COMPLETED
Registry status
Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see how lofexidine (investigational study formulation drug) is absorbed, broken down, and removed from the body. To do this, a special form of the study drug will be used that has a radioactive carbon atom attached. Blood, urine, and feces samples will be collected at different times to measure the amount of the study drug and radioactivity they contain. The amount of radioactivity you will be exposed to is less than the amount of radiation from a regular X-ray.

Conditions Studied

Interventions

  • DRUG Lofexidine hydrochloride

Study Locations (1)

Texas

  • Worldwide Clinical Trials - San Antonio

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2012-05
Est. Completion 2012-06
Phase Phase 1

Sponsor

USWM, LLC (dba US WorldMeds)

16 total trials

What the Registry Record Tells You About NCT01629446

The ClinicalTrials.gov registry entry for NCT01629446 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USWM, LLC (dba US WorldMeds), which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Normal Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Lofexidine hydrochloride is the first listed.

NCT01629446 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01629446 about?

NCT01629446 is a clinical study titled "Lofexidine Mass Balance in Volunteers". The purpose of this study is to see how lofexidine (investigational study formulation drug) is absorbed, broken down, and removed from the body. To do this, a special form of the study drug will be used that has a radioactive carbon atom attached. Blood, urine, and feces samples will be collected at...

What is the current status of trial NCT01629446?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2012-05. Estimated completion is 2012-06.

What conditions does trial NCT01629446 study?

This clinical trial studies the following conditions: Normal Healthy Volunteers.

What interventions are being tested in trial NCT01629446?

The interventions under investigation include: Lofexidine hydrochloride (DRUG).

Who is sponsoring clinical trial NCT01629446?

This trial is sponsored by USWM, LLC (dba US WorldMeds), which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01629446 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.